Rosetta Omics
Paris · Founded 2022
About Rosetta Omics
Rosetta Omics diagnoses and stratifies first-line cancer treatment options for oncologists, clinicians, and pathologists.
Company Facts
- Founded: 2022
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (May 2024)
- Website: rosettaomics.fr
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/rosetta-omics-8390469 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.